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Occupational  exposure  to toxic  heavy  metals  renders  the  industrial  workers  with  vari-
ous  health  problems.  Many  heavy  metals  act as endocrine  disruptors.  Chromium  salts  are
commonly  used  in  industries  as  asbestos  brake  lining,  cement  dust and  food  additives.
Thyroid  is a metabolically  active  important  endocrine  gland.  Little  is known  about  the  toxic
effects  of  chromium  on  thyroid.  So,  the  aim  of  this  study  was  evaluation  of the  histological
changes  induced  by chromium  on  thyrocytes  and  the  possible  protective  role  of  vitamin  C.
Forty adult  male  albino  rats  were divided  into  four  equal  groups:  control  group,  vitamin  C
treated  group,  potassium  dichromate  treated  group  and  the  fourth  group  co  treated  with
potassium dichromate  and  vitamin  C. Potassium  dichromate  was  given  intraperitonially  for
2 weeks  at a  dose  2 mg/kg  daily.  Vitamin  C was  given  at a dose  120 mg/kg  orally  daily  for
the  same  period.  Specimens  were  processed  for light and  electron  microscopy.  Apoptosis
was  evaluated  immunohistochemically.  Specimens  of  potassium  dichromate  group  showed
disturbance  of the  normal  architecture  of the  gland  with  coalescence  and  degeneration  of
thyroid follicles  and  desquamated  cells  in  its  lumen.  Disruption  of  the  apical  and  basal
membranes  of  some  thyrocytes,  ﬂattened  hyperchromatic  nuclei,  dilated  RER  and  swollen
degenerated  mitochondria  were  also  noted.  Immunohistochemically,  there  were  changes
in the  immune  expression  of  Bcl2  in  the  cytoplasm  of thyrocytes.  Vitamin  C  supplemented
group  showed  partial improvement  of the  previous  changes.  So,  potassium  dichromate
induced  structural  changes  in the  thyroid  follicular  cells  that  were  partially  improved  by
vitamin  C supplementation.
© 2014  Saudi  Society  of  Microscopes.  Published  by  Elsevier  Ltd.  All  rights  reserved.. Introduction
Chromium (Cr) is a naturally occurring heavy metal
ound in rocks, volcanic dust and gases, soils as well as
lants  and animals. Chromium compounds are used in
aints,  metal ﬁnishes, and stainless steel. Increased usage
f  hexavalent chromium (CrVI) and its improper disposal
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213-879X/© 2014 Saudi Society of Microscopes. Published by Elsevier Ltd. All rilead to various health hazards [1,2]. However, chromium
in  a small amount is considered an important nutrient
responsible for carbohydrate metabolism [3].
Chromium is present in two  forms: trivalent Cr(III)
which is poorly transported across membranes and hexa-
valent  Cr(VI) can readily cross cellular membranes. Inside
the  cell, the hexavalent form is reduced to the triva-
lent form. This biotransformation process reduces the
toxicity because the trivalent form does not cross cel-
lular  membrane rapidly. The trivalent form complexes
with intracellular macromolecules, these toxic compounds
ghts reserved.
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are responsible for many toxic and mutagenic effects of
chromium, not biodegradable and accumulate in the envi-
ronment  [4,5].
Hexavalent chromium usually linked with oxygen form-
ing  strong oxidizing agent that is widely known to cause
allergic dermatitis as well as toxic and carcinogenic effects
in  humans and animals [6]. The fate of chromium in the
environment is dependent on its oxidation state. Hexa-
valent chromium primarily enters the cells and undergoes
metabolic reduction to trivalent chromium, resulting in the
formation  of reactive oxygen species together with oxida-
tive  tissue damage and a cascade of cellular events [7].
Occupational exposure to Cr is found among approxi-
mately half a million industrial workers worldwide. Also,
water  contaminated with hexavalent chromium is a world-
wide  problem, as it is the major route of chromium
exposure for the general population [8,9]. Potassium
dichromate (K2Cr2O7) is a soluble hexavalent chromium
compound that is widely used in several industries [10].
Ascorbic  acid (vitamin C) is as an essential micronutri-
ent that performs important metabolic function in human
[11].  It also acts as a biological antioxidant by donating an
electron  to free radical species, such as tocopherol radical,
thereby interrupting the radical chain reaction in biological
membranes [12].
Vitamin  C has been reported to function as a major
reductant of Cr(VI) in animals and cell culture systems [13].
From  these points it was important to evaluate the effect
of  potassium dichromate on the thyroid gland of rats and
the  possible protective effect of vitamin C.
2. Materials and methods
The  present work was carried out on 40 adult male
albino rats that were divided into four groups each, 10
rats.  Group one acts as a control group that was subdivided
into two subgroups: A positive control which received intra
peritoneal  injection of 1 ml  distilled water, the solvent of
the  material used in this work. The other subgroup B which
was  the negative subgroup that did not receive any treat-
ment  through the experiment.
The second group received vitamin C in dose of
120 mg/kg [14] orally for 2 weeks. The third group was
the  treated group received potassium dichromate in a dose
of  2 mg/kg [15] intra peritoneal per day for 2 weeks. The
fourth  group (the protective group) received the same dose
of  potassium dichromate concomitant with vitamin C in
the  same dose like the second one. Potassium dichromate
(K2Cr2O7) was supplied by El-Nasr pharmaceutical chemi-
cals  company ADWIC, Egypt.
At the end of the experiment the rats were anaes-
thetized (better with carbon dioxide). Mid  line incision was
done  with careful dissection of the neck to identify ster-
nohyoid and sternomastoid muscle. The muscles were then
separated  to expose the trachea. Trace the trachea upward
gently  until the thyroid glands were visible. It appeared as
two  small reddish oval masses on each side of the trachea.
Dissect the glands gently to avoid its injury [16]. The thy-
roid  glands were collected and divided into two parts. One
part  was processed for light microscope study using PAS
stain  and some sections used for immunohistochemicaly and Ultrastructure 2 (2014) 137–150
methods for detection of apoptosis using BCL2 immune
expression. The second part was processed for electron
microscope study. The blood was drawn directly from the
left  ventricle through cardiac puncture. It was used for
estimation of serum T3, T4 and TSH according to the instruc-
tions  of their referred methods using Milliplex.Map Rat
Thyroid  Hormone TSH panel-2 plex (EMD Millipore, Bil-
lerica,  MA,  USA). The biochemical data were expressed as
the  mean ± standard error using ANOVA test (f test) and
unpaired Student’s test (Scheffe test).
2.1. Immunohistochemical staining for detection of Bcl2
protein (antiapoptotic marker) [17]
Immunohistochemical reaction was  performed using
avidin biotin peroxidase technique. The primary antibody
was  a rabbit monoclonal antibody) Sigma Laboratories).
The universal kit was  avidin biotin peroxidase produced
by  Nova Castra Laboratories Ltd, UK.
Tissue sections were deparafﬁnized and rehydrated.
Slides were incubated in hydrogen peroxide (10%) for
10–15  min  to inhibit the activity of endogenous peroxi-
dase to reduce nonspeciﬁc background staining. Antigen
retrieval was done by immersing the sections in a pre-
heated citrate buffer solution (pH 6) and maintaining heat
in  a microwave at 2 W for 10–20 min. Sections were left to
cool  for 20 min  at room temperature. Slides were washed
for  2 times in buffer (0.05% sodium azide). Monoclonal
antibody Bcl2 Ab-1 (Ms-123-R7) was applied. Slides
were washed for 4 times in buffer (0.05% sodium azide).
Biotinylated goat anti-polyvalent was applied. Slides were
incubated for 10 min  at room temperature. Slides were
washed for 4 times in buffer (0.05% sodium azide). Chro-
mogenic substrate was applied (diaminobenzidine) DAB
and  incubated until desired reaction was achieved. Mayer’s
haematoxylin was used as a counter stain [18,19].
The Bcl2 cytoplasmic site of reaction was  stained brown
and  nuclei stained blue. The same method was  applied to
prepare  negative control sections but the primary antibody
was  not added. Tonsil was  used as positive control tissue
[20].
3.  Results
3.1. Biochemical results
Potassium  dichromate treated rats showed a signiﬁcant
decrease in the serum T3 and T4 and a signiﬁcant increase in
the  TSH levels when compared with control group and vita-
min  C treated group. In the protective group, there was a
signiﬁcant increase in the level of the T3 and T4 and a signif-
icant  decrease in the serum TSH compared with potassium
dichromate treated group (Tables 1–3).
3.2. Light microscopic results
3.2.1.  Control and vitamin C treated groups
Examination of the semi-thin sections obtained from
the  thyroid glands of the control group and vitamin C
treated showed the normal histological structure. The thy-
roid  gland was  formed of follicles of various sizes, each
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Table 1
The  mean level of serum tri-iodothyronine (T3) in different studied groups.
T3
GI GII GIII GIV
Mean 112.2 116 81 98
±SD  25.6 19.3 15.3 12.7
f  test 6.325
p value 0.006*
Scheffe test
GI & GII GI & GIII GI & GIV GII & GIII GII & GIV GIII & GIV
0.052 NS 0.001* 0.009* 0.001* 0.006* 0.012*
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Histogram showing the me an level ofserum tri -iodothyronine (T3) in different 
studied groups.
S
f
c
c
r
p
F
ﬁD, standard deviation; NS, non-signiﬁcant.
* Signiﬁcant.
ollicle was lined with a single layer of cuboidal epithelial
ells and ﬁlled with homogenous colloid and separated by
apillary  beds (Fig. 1).
Basal  lamina of follicular cells showed moderate PAS
eaction while colloid showed marked reaction with
eripheral vacuolization (Fig. 2).
ig. 1. Photomicrographs of a semi-thin section of the thyroid gland of the con
lled  with homogeneous colloid (F) and separated by capillary beds (C) (ToluidinImmunohistochemically, there was  strong cytoplasmic
BCL2 expression in follicular cells (Fig. 3).3.2.2. Potassium dichromate treated group
Semi-thin sections of the thyroid gland of the potas-
sium dichromate treated rats showed complete loss of the
trol group showing thyroid follicles lined with cuboidal epithelium and
e blue, 1000×).
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Table 2
The  mean level of serum thyroxine (T4) in different studied groups.
T4
GI GII GIII GIV
Mean 9.3 6.96 4.9 4.7
±SD  1.63 1.20 0.36 0.63
f  test 3.265
p value 0.042*
Scheffe test
GI & GII GI & GIII GI & GIV GII & GIII GII & GIV GIII & GIV
0.142 NS 0.001* 0.001* 0.014* 0.010* 0.020*
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Histogram showing the mean level of serum thyroxine (T4) in different studied 
groups.
SD, standard deviation; NS, non-signiﬁcant.
* Signiﬁcant.
ing stro
pheral vFig. 2. Photomicrographs of the thyroid gland of the control group show
reaction  in the basal lamina. Notice, in (A) there are follicles with no peri
normal architecture of the thyroid gland. Disruption of
the  basal laminae of some follicles with their coalescence
was detected (Fig. 4). Some follicles appeared distended
with colloid lined with squamous epithelium, others were
completely collapsed. Some follicles were degenerated and
ﬁlled  with exfoliated cells (Fig. 5). Disruption of the apical
membranes of some thyrocytes with desquamated cyto-
plasm  and nuclei inside the follicles was observed. Some
thyrocytes appeared tall columnar with apical pseudo-
podia (Fig. 6). Vacuolization of the cytoplasm of someng PAS reaction in the colloid with peripheral vacuolation and moderate
acuolation (PAS, 400×).
thyrocytes, variable densities of colloid staining and widen-
ing  of the interfollicular space appeared in some sections
(Fig.  7).
Basal lamina of follicular cells showed a weak PAS
reaction while colloid showed a moderate reaction with
abnormal pattern of vacuolization and colloid retraction in
some  follicles (Fig. 8).Immunohistochemically, there was  negative cytoplas-
mic  BCL2 immunoexpression in the majority of follicular
cells (Fig. 9).
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Table 3
The  mean level of serum thyroid stimulating hormone (TSH) in different studied groups.
TSH
GI GII GIII GIV
Mean 0.01 0.01 0.12 0.01
±SD  0.01 0.01 0.02 0.01
f  test 1.362
p value 0.069*
Scheffe test
GI & GII GI & GIII GI & GIV GII & GIII GII & GIV
1.00 NS 0.001* 1.00 NS 0.001* 1.00 NS
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Histog ram showing the mean level of serum thyroid stimulating hormone (TSH) 
in different studied groups.
SD, standard deviation; NS, non-signiﬁcant.
* Signiﬁcant.
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dig. 3. Photomicrographs of the thyroid gland of the control group show
ells  (BCL2 immunoexpression, 400×, 1000×).
.2.3. Protective group (potassium dichromate + vitamin
)
Examination of semi-thin sections obtained from the
hyroid glands of rats of the protective group revealed
mprovement in the histological changes detected in the
revious  group. The thyroid gland started to regain its nor-
al  architecture. The densities of colloid staining were
lso  variable. However, some follicles still disrupted with
esquamated cells in the lumens. The thyrocytes appearedg BCL2 immunoexpression in the cytoplasm of the majority of follicular
less  vacuolated. The interfollicular spaces appeared nar-
rower  than the treated group (Figs. 10 and 11).
The basal lamina of the thyroid follicles showed appar-
ent  increase in the PAS reaction but less than the control
group. The colloid showed variable degrees of PAS reaction
and  still vacuolated (Fig. 12).
Immunohistochemically, there was apparent increase
in  the BCL2 expression in the cytoplasm of the thyroid fol-
licular  cells but less than the control group (Fig. 13).
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Fig. 4. A photomicrograph of a semi-thin section of the thyroid gland of
potassium dichromate treated group showing loss of the normal architec-
ture of the thyroid gland (F), the basal lamina of the follicles are disrupted
(arrows) with adherence of the follicles (Toluidine blue, 400×).
Fig. 5. Photomicrographs of a semi-thin section of the thyroid gland of potassiu
with  colloid (F), others appear collapsed (C). (B) Higher magniﬁcation of A, show
degenerated  (D) with desquamated cells in the lumen (arrows) (Toluidine blue, 4
Fig. 6. Photomicrographs of a semi-thin section of the thyroid gland of the same g
with  the presence of the cytoplasmic content in the lumen (S). Notice vacuolatio
(B)  Apical pseudopodia (thick arrows) of some thyrocytes while the others have vy and Ultrastructure 2 (2014) 137–150
3.3. Electron microscopic study
3.3.1. Control and vitamin C treated groups
EM examination of ultra-thin sections of the thyroid
glands of rats of the control and vitamin C treated groups
showing the same ultrastructure picture of normal thy-
roid  follicular cells. The thyrocytes appeared with rounded
euchromatic nuclei and numerous short apical microvilli.
Their cytoplasm contained RER, abundant mitochondria,
prominent Golgi apparatuses, SER, lysosomes, abundant
apical vesicles containing colloid and electron dense gran-
ules  (Fig. 14).
3.3.2.  Potassium dichromate treated group
EM examination of ultra-thin sections of the thyroid
glands of this group conﬁrmed the light microscopic exam-
ination.  Some of the thyrocytes were squamous with ﬂat
hyperchromatic nuclei, others were pyramidal or prism
like.  Stratiﬁcation of the lining epithelium of some fol-
licles  and desquamated cells appeared in the follicular
lumens (Fig. 15). The cytoplasm showed variable sized
vacuoles with dilated RER with disruption of the api-
cal  membrane of some thyrocytes and exfoliated cells
m dichromate treated group showing: (A) some follicles are distended
ing some of thyroid follicles appeared collapsed (C), while the others are
00×, 1000×).
roup showing (A) disruption of the apical membranes of some thyrocytes
n of the cytoplasm of the other thyrocytes in the same follicle (arrows).
acuolated cytoplasm (thin arrows) (Toluidine blue, 1000×).
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Fig. 7. Photomicrographs of a semi-thin section of the thyroid gland of the same group showing (A) widening of the interfollicular space (stars) and variable
densities  of the colloid staining (v). (B) Mast cells in the interfollicular space (arrows) (Toluidine blue, 1000×).
Fig. 8. Photomicrographs of the thyroid gland of potassium dichromate treated g
the  basal lamina with (A) absence of peripheral vacuolation and (B) abnormal pat
Fig. 9. A photomicrograph of the thyroid gland of potassium dichromate
treated group showing negative immune expression of BCL2 in the cyto-
p
w
t
c
f
(
sible  protective role of vitamin C. The study revealed the
effects  of chromium compound on the thyroid gland whichlasm of the majority of follicular cells (BCL2 immunoexpression, 1000×).
ere present inside the lumens (Fig. 16). In some sec-
ions there is rarefaction of the cytoplasm with loss of the
ytoplasmic organelles swollen degenerated mitochondria,
ragmented RER and the presence of large sized vacuole
Fig. 17).roup showing moderate PAS reaction in the colloid and weak reaction in
tern of vacuolization and colloid retraction (PAS, 400×).
3.3.3.  Protective group (potassium dichromate + vitamin
C)
The follicular cells of this group appeared more or less as
the  control group. However, some thyrocytes still have vac-
uolated  cytoplasm, dilated RER and hyperchromatic nuclei
(Figs.  18 and 19).
4.  Discussion
Hexavalent chromium (CrVI) has been widely used in
industries throughout the world. Increased its usage and
atmospheric emission of CrVI from catalytic converters
of automobiles, and its improper disposal cause various
health hazards [2].
Today,  it is known that there is a close relationship
between workers health and the amounts of industrial pol-
lution  provoked by industries manufacturing chromium
containing materials. So, numerous and different in vitro
and/or  in vivo studies on chromium have been undertaken
either in animals or in human [21].
The present work studied the effect of potassium
dichromate on the thyroid gland structure and the pos-appeared in the form of irregularity in size and shape
of the follicles. Some of them were lined with squamous
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Fig. 10. Photomicrographs of a semi-thin section of the thyroid gland of the protective group showing: (A) restoration of the normal architecture of the
thyroid  gland (F). (B) Disruption of the basal lamina of the thyroid follicles (arrows) (Toluidine blue, 400×).
Fig. 11. Photographs of a semi-thin section of the thyroid gland of the same group showing (A) the thyroid follicles appear more or less as the control (F)
(Toluidine  blue, 400×). (B) Higher magniﬁcation of A showing vacuolization (arrows) of the cytoplasm of some thyrocytes (Toluidine blue, 1000×).
 showin
ear witFig. 12. Photomicrographs of the thyroid gland of the protective group
lamina,  some follicles showing peripheral vacuolization, while others app
epithelium, others lined with cubical and the third group
of  follicles were lined with tall columnar cells with apical
pseudopodia. Interfollicular spaces were widened either as
a  result of collapse of some follicles or due to necrosis of the
others  leaving empty spaces. The cytoplasm of some follic-
ular  cells appeared vacuolated and even desquamation of
some  cells into the lumens were seen in the majority of
sections.g strong PAS reaction in the colloid and moderate reaction in the basal
h central vacuolization, the rest appear inactive (PAS, 400×).
Other  work reported that, administration of sodium
dichromate in the drinking water to rats and mice resulted
in  focal ulceration, hyperplasia, and metaplasia in the glan-
dular  stomach and hyperplasia of the duodenum [22]. Also,
histological analysis of the effect of chromium on male
reproductive system revealed pronounced morphological
alterations with enlarged intracellular spaces and tissue
loosening [15].
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The present work revealed increase in the interfollic-
lar spaces and disruption of the basal lamina of follicles
nd  these ﬁndings were coincided with other studies [23].
he  latter reported decrease in the size of follicles and
idening of the interfollicular spaces and attributed this
idening to disruption of the connective tissue. At the end
hey  concluded that Cr(VI) is potentially toxic to the thy-
oid  gland. Also, another studies found the same results
ith irregularity and shrunken of some follicular cells
ncrease in the number of disorganized and collapsed fol-
icles.  Hyperplasia of follicular cells and nuclei appeared
val, rounded, irregular and even shrunken. They added
hat  disruption of the apical and basal laminae were seen
24].
Disorganization of the thyroid follicles and cytoar-
hitecture indicate high level of toxicity caused by the
hromium. TSH is responsible for the morphological
ppearance of thyroid follicles and the synthesis and secre-
ion  of thyroid hormones leading to hypertrophy and
yperplasia of the follicular cell. One of the early responses
f  TSH-stimulated thyroid follicular cells is engulfment of
olloid  material from the follicular lumen into the apical
ytoplasm of thyrocytes, in the form of membrane-bound
olloid droplets. Administration of TSH to rats pretreated
ith thyroxin resulted in the formation of numerous pseu-
opods  on the apical surface of thyrocytes, followed by the
ppearance of colloid droplets, at ﬁrst in the apical and
ater  on in the deeper parts of the cytoplasm. It was  also
tated that the percentage of follicular cells containing col-
oid  droplets and the number of droplets in cells gradually
ncreased with the increase of TSH dose [23,25].
However, irregularity in the size of follicles in some ani-
als  may  be normal, as the size distribution pattern of
hyroid  follicles is different between the peripheral and
entral  gland regions. In rats, the larger thyroid gland fol-
icles  are mostly located at the periphery of the thyroid
ig. 14. (A) Ultrathin section of the thyroid gland of the control group showing 
ER  (r), scattered electron dense vesicles (arrows). (B) Higher magniﬁcation of (A
esicles  (arrows).Fig. 13. A photomicrograph of the thyroid gland of the protective group
showing positive cytoplasmic reaction for BCL2 (BCL2 immunoexpression,
1000×).
lobes stated that the large follicles at periphery mainly
serve as a pool of old hormone, whereas the smaller, cen-
trally  distributed ones are responsible for thyroid hormone
secretion [26,27].
Variation in the nuclear shape and size was  characteris-
tic ﬁnding in this work and explained by some authors that
increased  nuclear area is often observed in compounds that
block  cell cycle and induce DNA damage [28].
Bcl-2 is an apoptosis-related molecule that was shown
to  be down-regulated during the early events leading to
programmed cell death and its protein might be as an
inhibiting molecule and play an important role in the bal-
ance  between apoptosis promotion and inhibition [29,30].
The  detection of apoptosis in the follicular cells in
this study which was explained in many other studies
[31,32]. They stated that CrVI induced DNA fragmentation,
follicular cells with apical microvilli containing euchromatic nuclei (N),
) showing parts of two follicular cells, containing RER (r), electron dense
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Fig. 15. (A) Ultrathin section of the thyroid gland of the potassium dichromate treated group showing two  thyrocytes one of them is squamous with
ﬂat  hyperchromatic nucleus (N1) and the other is prism like with irregular hyperchromatic nucleus (N2). (B) Stratiﬁcation of the lining epithelium (S),
vacuolation  of the cytoplasm (V) and exfoliated cells in the lumen (curved arrows).
ate trea
) with th
lls (arroFig. 16. Ultrathin section of the thyroid gland of the potassium dichrom
(curved  arrow). (B) Higher magniﬁcation of (A) showing dilated RER (R
complete  loss of the microvilli on the apical membrane of the follicular ce
increased apoptosis, increased cytochrome c release from
the  mitochondria to cytosol, down regulated anti-apoptotic
Bcl-2 and other mediators; upregulated pro-apoptotic
[2]. Also it was documented that potassium dichromate-
induced apoptosis and oxidative stress in the hepatocytes
of Wistar rats.Some  authors explained in details the mechanism by
which  the Cr(VI) lead to apoptosis. They hypotheses that
soluble  Cr(VI) is metabolized within cells by reductiveted group showing (A) dilated RER (R) and exfoliated cells in the lumen
e presence of various sized electron dense bodies (arrows). Notice the
w head).
agents including ascorbic acid, glutathione and cysteine
and a diverse range of genetic lesions are generated. Some
forms  of Cr damage present physical barriers to DNA repli-
cation/transcription and promote a terminal cell fate such
as  apoptosis or terminal growth arrest. Other DNA lesions
are  potentially pre-mutagenic and lead to DNA damage and
cell  cycle arrest [33–35].
The  electron microscopic results conﬁrmed the results
obtained by the light microscope. Some follicles were
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Fig. 17. Ultrathin section of the thyroid gland of the potassium dichromate treated group showing (A) a thyrocyte with large sized vacuole (V), rariﬁed
cytoplasm  (star), swollen degenerated mitochondria (curved arrows), fragmented RER (r) and ﬂat hyperchromatic nucleus (N). (B) Thyrocytes with irregular
shaped  nucleus (N) rariﬁed cytoplasm (star), fragmented RER (r) as well as partial loss of the apical microvilli (arrows).
F  showin
o (V). (B) A
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aig. 18. (A) Ultrathin section of the thyroid gland of the protective group
f  the apical membrane (curved arrows) and small cytoplasmic vacuoles 
ined with low prismatic, cuboidal or ﬂattened epithe-
ium with apparent decrease in epithelial height. That
as  attributed to hypoactivity of the thyroid gland. This
as  conﬁrmed by biochemical changes in this work in
he  form of decrease in T3 and T4 level and increase
n the TSH level [36]. Others showed stratiﬁcation of
heir  lining epithelium. The nuclei of thyrocytes appeared
hrunked hyperchromatic nuclei, fragmented and dilated
ER,  swollen mitochondria with degenerated cristae,
ccumulation of colloid vesicles inside the thyrocytes, eveng (A) thyrocytes appear more or less as the control except for disruption
 thyrocyte with intact mitochondria (M), RER (R) appear as the control.
complete  loss of all the cytoplasmic organelles. Similar
results observed previously in the form of disrupted basal
laminae of the follicles, regressed nuclei and disrupted cell
organelles [24]. Also, follicular hyperplasia may be con-
nected  with a cascade of cellular events involving oxidative
stress, genomic DNA damage, and modulation of apop-
53totic  regulatory gene (P ) after exposure to chromium
[37]
The mechanism of chromium toxicity was  reported to
be  associated with mitochondrial and lysosomal injury by
148 R.H. ElBakry, S.M. Tawﬁk / Journal of Microscopy and Ultrastructure 2 (2014) 137–150
p show
ilated REFig. 19. (A) Ultrathin section of the thyroid gland of the protective grou
shaped  nuclei (N), rariﬁed cytoplasm (white stars). (B) A thyrocyte with d
(arrows)  with loss of the apical microvilli (curved arrow).
biologically Cr(VI) reactive intermediates and reactive oxy-
gen  species [4]. The results demonstrated that potassium
dichromate was highly cytotoxic to cells, and its cytotox-
icity  seems to be mediated by oxidative stress and DNA
damage [7]. The results indicated that administration of
Cr(VI)  had caused a signiﬁcant increase of reactive oxygen
species (ROS) level generated during reduction of Cr(VI)
[38,39].
Previous studies both in vitro and in vivo have demon-
strated that chromium(VI) induces an oxidative stress
through enhanced production of reactive oxygen species
(ROS)  leading to genomic DNA damage and oxidative
deterioration of lipids and proteins. A cascade of cellular
events occur following chromium (VI)-induced oxidative
stress including enhanced production of superoxide anion
and  hydroxyl radicals, increased lipid peroxidation and
genomic  DNA fragmentation, modulation of intracellular
oxidized states, activation of protein kinase C, apoptotic
cell death and altered gene expression [40–42].
In a recent study demonstrated that catalase is a
classical oxidative biomarker and is the most abundant
in peroxisomes, where oxidative stress most frequently
occurs [43,44]. The increase in these enzyme activities sug-
gests  a response toward increased ROS generation [45,46].
Previously, it was reported that Cr(VI) induced thyroid
toxicity through increasing cellular oxidative stress and
decreasing the activity of antioxidants [47].
Some authors explained that Cr(VI) accumulates in
the  pituitary and hypothalamus resulting in apopto-
sis evidenced by nuclear fragmentation and caspase 3
activation. Their results indicate that the anterior pitu-
itary  gland can be a target of Cr(VI) toxicity in vivo
and in vitro, thus producing a negative impact on the
hypothalamic–pituitary-axis and affecting the normal
endocrine function [9,48].ing part of thyroid follicle in which the thyrocytes appear with variable
R (R) and irregular hyperchromatic nuclei (N) and electron dense bodies
Some researches observed hypertrophic follicular cells
contain dilated r-ER and colloid droplets. Follicles were
lined  by tall columnar cells and vacuolated mitochondria
with disrupted cristae. They explained their results due
to  Goitrogenic effects of a soybean diet which result in
increased thyroid stimulating hormone leading to hyper-
plasia  in thyroid gland [49].
As regard to the thyroid hormone level there was
decrease in the level of free T3 and T4. The protective
group revealed more or less normal value near to that of
the  control group. The same results were documented in
other  works which showed signiﬁcantly increased TSH and
decreased  FT3 and FT4 concentrations in protective group
serum  TSH, FT3 and FT4 concentrations neared control [14].
It  was  reported that Cr toxicity led quite possibly to a state
of  hypothyroidism as indicated by a signiﬁcant increase in
the  serum TSH and a decrease in the serum FT3 and FT4
concentrations [50].
Vitamin  C administration in this work showed some
improvement in the thyroid gland function and structure.
As,  the level of the thyroid hormones became near to the
control  one. Also, the thyroid gland regained its normal cel-
lular  architecture and appeared more or less near to the
control.
Previous studies detected that early and repeated high
intravenous doses of vitamin C was  the therapy of choice
for  Cr(VI) poisoning [51]. Also the results of [52] showed
that vitamin C had antimutagenic effect against chromium
compound.
Also it was  found that administration of exogenous
ascorbic acid has been used in the treatment of systemic
chromium poisoning and chromium dermatitis as it
enhances the extracellular reduction of chromium(VI)
[53]. Ascorbic acid inﬂuenced Cr(VI) toxicity either by
acting  as a reducing agent, decreasing Cr(V) persistence or
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y acting as an antioxidant, decreasing intracellular super-
xide  anion and hydrogen peroxide formation and also it
cts  by reducing free radicals formed during reduction of
r(VI)  to Cr(III) [54].
Many  works concluded that co-administration of vit
 and E may, signiﬁcantly diminish the toxic effects of
exavalent chromium on lung [55]. Simultaneous admin-
stration of vitamin C signiﬁcantly prevented the increase
n  lipid peroxidation and enhanced the antioxidant sta-
us.  These results proved the protective effect of vitamin
 against the Cr(VI) exposure-induced toxicity and test
he  signiﬁcance of antioxidants in diet [3]. The functional
hanges cannot be completely replenished by the ascorbic
cid  supplementation in response to chromium exposure
56].  However, other works proved that the ascorbic acid
ay  have the potential to protect thyroid gland from
hromium toxicity [14].
.  Conclusion
It  could be concluded that potassium dichromate had
oxic  effects on the thyroid follicular cells, which partially
mproved with vitamin C co-treatment. So, it is recom-
ended to give vitamin C as a protective agent against
hromium toxicity in people who are susceptible for con-
inuous  exposure.
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